ADVERTISEMENT
Niva Bupa Q4 Results Review — Motilal Oswal Maintains 'Buy' On Robust Operational Performance
Backed by Niva's strong performance in Q4 FY25, Motilal Oswal has upgraded its estimates under IGAAP, mainly on expense ratio and slightly higher growth.
08 May 2025, 11:54 AM IST 
Niva Bupa Health Insurance Co. reported 25% YoY growth in NEP to Rs 14.4 billion (in-line) in Q4 FY25.
(Photo source: Envato)
Niva launched a new product in Q4 FY25 for the middle-class and lower-middleclass segment, which is one of the largest unserved populations. 80% of claims come from 100 preferred provider networks. The company actively removes hospitals based on their cost practices, service, and quality.
I’m already a Subscriber
To continue reading this storySubscribe to Unlock & Enjoy your
Subscriber-Only benefits
Subscriber-Only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Subscriber-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Subscriber-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
